| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 39 | 2023 | 1697 | 4.780 |
Why?
|
| Cardiac Surgical Procedures | 33 | 2022 | 1237 | 4.000 |
Why?
|
| Extracorporeal Membrane Oxygenation | 20 | 2021 | 581 | 3.180 |
Why?
|
| Intensive Care Units, Pediatric | 22 | 2022 | 441 | 2.300 |
Why?
|
| Tetralogy of Fallot | 9 | 2019 | 149 | 1.590 |
Why?
|
| Cardiopulmonary Bypass | 11 | 2021 | 422 | 1.570 |
Why?
|
| Infant | 70 | 2023 | 13310 | 1.550 |
Why?
|
| Acute Kidney Injury | 5 | 2022 | 739 | 1.540 |
Why?
|
| Child Development | 7 | 2022 | 255 | 1.510 |
Why?
|
| Developmental Disabilities | 8 | 2020 | 674 | 1.430 |
Why?
|
| Hypoplastic Left Heart Syndrome | 8 | 2021 | 218 | 1.410 |
Why?
|
| Cardiotonic Agents | 5 | 2019 | 151 | 1.380 |
Why?
|
| Health Information Systems | 2 | 2020 | 34 | 1.370 |
Why?
|
| Airway Extubation | 8 | 2021 | 65 | 1.350 |
Why?
|
| Child | 73 | 2023 | 29154 | 1.250 |
Why?
|
| Postoperative Complications | 15 | 2022 | 5542 | 1.250 |
Why?
|
| Perioperative Period | 4 | 2020 | 155 | 1.240 |
Why?
|
| Infant, Newborn | 49 | 2022 | 8223 | 1.220 |
Why?
|
| Hydrazones | 4 | 2014 | 42 | 1.210 |
Why?
|
| Hydrocortisone | 3 | 2018 | 388 | 1.150 |
Why?
|
| Respiration, Artificial | 12 | 2021 | 577 | 1.070 |
Why?
|
| Cardiac Output | 10 | 2014 | 194 | 1.070 |
Why?
|
| Vasodilator Agents | 4 | 2017 | 219 | 1.060 |
Why?
|
| Critical Illness | 11 | 2023 | 714 | 1.050 |
Why?
|
| Hypertension, Pulmonary | 8 | 2012 | 462 | 1.010 |
Why?
|
| Pyridazines | 4 | 2014 | 293 | 1.010 |
Why?
|
| Length of Stay | 12 | 2021 | 1900 | 1.000 |
Why?
|
| Brain Injuries | 4 | 2014 | 787 | 0.940 |
Why?
|
| Norwood Procedures | 3 | 2016 | 84 | 0.910 |
Why?
|
| Child, Preschool | 39 | 2021 | 16273 | 0.890 |
Why?
|
| Pandemics | 9 | 2023 | 1559 | 0.880 |
Why?
|
| Hypernatremia | 1 | 2023 | 33 | 0.860 |
Why?
|
| Myocarditis | 2 | 2021 | 190 | 0.850 |
Why?
|
| Hyponatremia | 1 | 2023 | 82 | 0.820 |
Why?
|
| Hypoxia, Brain | 3 | 2011 | 31 | 0.810 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2023 | 92 | 0.810 |
Why?
|
| Hospital Mortality | 10 | 2020 | 1274 | 0.800 |
Why?
|
| Aortic Coarctation | 5 | 2021 | 103 | 0.790 |
Why?
|
| Meconium Aspiration Syndrome | 4 | 2010 | 15 | 0.780 |
Why?
|
| Humans | 135 | 2023 | 261506 | 0.770 |
Why?
|
| Nitric Oxide | 4 | 2006 | 644 | 0.750 |
Why?
|
| Cardiovascular System | 2 | 2022 | 145 | 0.750 |
Why?
|
| Cardiac Output, Low | 5 | 2007 | 81 | 0.740 |
Why?
|
| Postoperative Care | 9 | 2019 | 739 | 0.730 |
Why?
|
| Ventilators, Negative-Pressure | 4 | 2000 | 5 | 0.680 |
Why?
|
| Oxygen | 5 | 2018 | 754 | 0.670 |
Why?
|
| Electroencephalography | 3 | 2012 | 898 | 0.670 |
Why?
|
| Retrospective Studies | 44 | 2023 | 37905 | 0.670 |
Why?
|
| Prospective Studies | 28 | 2021 | 12873 | 0.650 |
Why?
|
| Oxygen Consumption | 5 | 2010 | 401 | 0.640 |
Why?
|
| Milrinone | 3 | 2019 | 33 | 0.640 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2016 | 137 | 0.620 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 2195 | 0.610 |
Why?
|
| Systemic Inflammatory Response Syndrome | 6 | 2022 | 182 | 0.610 |
Why?
|
| Respiratory Insufficiency | 6 | 2014 | 330 | 0.600 |
Why?
|
| Pulmonary Circulation | 5 | 2016 | 131 | 0.590 |
Why?
|
| Hospitalization | 7 | 2021 | 2083 | 0.590 |
Why?
|
| Piperazines | 5 | 2006 | 2101 | 0.580 |
Why?
|
| Telemedicine | 2 | 2021 | 471 | 0.580 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2018 | 318 | 0.580 |
Why?
|
| Cannabinoids | 1 | 2016 | 38 | 0.560 |
Why?
|
| Cardiology | 2 | 2019 | 530 | 0.550 |
Why?
|
| Hemodynamics | 11 | 2022 | 935 | 0.540 |
Why?
|
| Coronavirus Infections | 2 | 2022 | 651 | 0.540 |
Why?
|
| Polycythemia | 1 | 2016 | 49 | 0.540 |
Why?
|
| Pneumonia, Viral | 2 | 2022 | 715 | 0.540 |
Why?
|
| Marijuana Abuse | 1 | 2016 | 67 | 0.540 |
Why?
|
| Risk Factors | 22 | 2023 | 17523 | 0.540 |
Why?
|
| Myocardial Contraction | 1 | 2017 | 291 | 0.530 |
Why?
|
| Transposition of Great Vessels | 3 | 2013 | 124 | 0.520 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2006 | 66 | 0.510 |
Why?
|
| Male | 59 | 2023 | 123000 | 0.510 |
Why?
|
| Tracheostomy | 3 | 2020 | 243 | 0.500 |
Why?
|
| Female | 64 | 2023 | 141928 | 0.500 |
Why?
|
| Hernia, Diaphragmatic | 2 | 2006 | 121 | 0.490 |
Why?
|
| Adolescent | 32 | 2022 | 31252 | 0.490 |
Why?
|
| Critical Care | 10 | 2022 | 770 | 0.460 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 502 | 0.460 |
Why?
|
| Referral and Consultation | 1 | 2019 | 899 | 0.460 |
Why?
|
| Brain | 6 | 2016 | 4113 | 0.460 |
Why?
|
| Sulfones | 5 | 2006 | 143 | 0.450 |
Why?
|
| Shock | 3 | 2022 | 88 | 0.450 |
Why?
|
| Life Support Care | 1 | 2013 | 50 | 0.450 |
Why?
|
| Heart Failure | 6 | 2020 | 2516 | 0.440 |
Why?
|
| Time Factors | 23 | 2022 | 12926 | 0.440 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2013 | 54 | 0.440 |
Why?
|
| Hospitals, Pediatric | 7 | 2022 | 773 | 0.430 |
Why?
|
| Regional Blood Flow | 2 | 2013 | 276 | 0.430 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 122 | 0.430 |
Why?
|
| Anti-Infective Agents | 1 | 2016 | 446 | 0.430 |
Why?
|
| Multiple Organ Failure | 3 | 2023 | 177 | 0.420 |
Why?
|
| Heart-Assist Devices | 2 | 2019 | 1171 | 0.410 |
Why?
|
| Atrial Fibrillation | 1 | 2019 | 719 | 0.410 |
Why?
|
| Nervous System | 4 | 2019 | 165 | 0.410 |
Why?
|
| Cross Infection | 1 | 2016 | 544 | 0.410 |
Why?
|
| Head | 1 | 2013 | 249 | 0.400 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2012 | 105 | 0.400 |
Why?
|
| Vitamin D Deficiency | 1 | 2012 | 115 | 0.400 |
Why?
|
| Dobutamine | 1 | 2011 | 54 | 0.390 |
Why?
|
| Treatment Outcome | 28 | 2020 | 32848 | 0.370 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 20 | 0.370 |
Why?
|
| Urotensins | 2 | 2010 | 4 | 0.370 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2010 | 22 | 0.370 |
Why?
|
| Preoperative Care | 4 | 2013 | 1529 | 0.360 |
Why?
|
| Victoria | 6 | 2013 | 17 | 0.360 |
Why?
|
| Calcium Channel Blockers | 1 | 2010 | 135 | 0.360 |
Why?
|
| Cooperative Behavior | 3 | 2016 | 313 | 0.350 |
Why?
|
| Extracorporeal Circulation | 1 | 2009 | 43 | 0.350 |
Why?
|
| Heart | 3 | 2021 | 1223 | 0.350 |
Why?
|
| Pediatrics | 6 | 2018 | 1141 | 0.350 |
Why?
|
| Heart Arrest | 1 | 2014 | 358 | 0.350 |
Why?
|
| Cognition Disorders | 2 | 2016 | 786 | 0.330 |
Why?
|
| Thrombelastography | 1 | 2009 | 79 | 0.330 |
Why?
|
| Malnutrition | 3 | 2023 | 218 | 0.320 |
Why?
|
| Steroids | 1 | 2010 | 356 | 0.320 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 128 | 0.320 |
Why?
|
| Veins | 1 | 2009 | 157 | 0.310 |
Why?
|
| Catheterization | 2 | 2014 | 410 | 0.310 |
Why?
|
| Cohort Studies | 12 | 2022 | 9244 | 0.310 |
Why?
|
| Hypnotics and Sedatives | 3 | 2019 | 218 | 0.310 |
Why?
|
| Texas | 7 | 2020 | 6311 | 0.310 |
Why?
|
| Risk Assessment | 2 | 2020 | 6869 | 0.300 |
Why?
|
| Hospital Costs | 2 | 2019 | 228 | 0.300 |
Why?
|
| Quality Improvement | 4 | 2016 | 851 | 0.300 |
Why?
|
| Heparin | 1 | 2009 | 360 | 0.300 |
Why?
|
| Pulmonary Artery | 4 | 2018 | 499 | 0.290 |
Why?
|
| Ventricular Dysfunction | 1 | 2006 | 33 | 0.290 |
Why?
|
| Prenatal Diagnosis | 2 | 2009 | 590 | 0.290 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 444 | 0.280 |
Why?
|
| Alprostadil | 1 | 2006 | 33 | 0.280 |
Why?
|
| Sildenafil Citrate | 5 | 2006 | 53 | 0.280 |
Why?
|
| Nutritional Support | 2 | 2016 | 80 | 0.270 |
Why?
|
| Anesthetics | 2 | 2019 | 115 | 0.270 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 2403 | 0.270 |
Why?
|
| Child Behavior | 2 | 2019 | 243 | 0.270 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2018 | 1303 | 0.260 |
Why?
|
| Biomarkers | 5 | 2020 | 5047 | 0.260 |
Why?
|
| Nervous System Diseases | 3 | 2022 | 500 | 0.260 |
Why?
|
| Heart Transplantation | 3 | 2020 | 908 | 0.260 |
Why?
|
| Anticoagulants | 2 | 2013 | 787 | 0.260 |
Why?
|
| Fontan Procedure | 2 | 1997 | 155 | 0.260 |
Why?
|
| Organ Dysfunction Scores | 2 | 2022 | 66 | 0.260 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2006 | 324 | 0.260 |
Why?
|
| Longitudinal Studies | 4 | 2016 | 1945 | 0.250 |
Why?
|
| Intensive Care, Neonatal | 1 | 2005 | 53 | 0.250 |
Why?
|
| Swine | 4 | 2007 | 1541 | 0.250 |
Why?
|
| Endothelin A Receptor Antagonists | 1 | 2004 | 11 | 0.250 |
Why?
|
| Shock, Septic | 2 | 2021 | 181 | 0.250 |
Why?
|
| Emotions | 2 | 2021 | 562 | 0.250 |
Why?
|
| Dietary Proteins | 2 | 2016 | 241 | 0.250 |
Why?
|
| Receptor, Endothelin A | 1 | 2004 | 18 | 0.250 |
Why?
|
| Palliative Care | 3 | 2014 | 2037 | 0.250 |
Why?
|
| Sodium | 2 | 2023 | 353 | 0.250 |
Why?
|
| Purines | 5 | 2006 | 273 | 0.240 |
Why?
|
| Coronary Care Units | 2 | 2015 | 46 | 0.240 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 708 | 0.240 |
Why?
|
| Databases, Factual | 3 | 2020 | 2218 | 0.240 |
Why?
|
| Risk | 2 | 2020 | 1972 | 0.230 |
Why?
|
| Administration, Inhalation | 4 | 2006 | 285 | 0.230 |
Why?
|
| Peptides, Cyclic | 1 | 2004 | 139 | 0.230 |
Why?
|
| Postoperative Period | 3 | 2014 | 665 | 0.230 |
Why?
|
| Stroke Volume | 3 | 2021 | 577 | 0.230 |
Why?
|
| Ventilator Weaning | 2 | 2015 | 32 | 0.230 |
Why?
|
| Schools | 2 | 2023 | 233 | 0.230 |
Why?
|
| Program Evaluation | 2 | 2018 | 597 | 0.220 |
Why?
|
| Age Factors | 8 | 2021 | 5377 | 0.220 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2005 | 199 | 0.220 |
Why?
|
| Decompression, Surgical | 2 | 2019 | 143 | 0.220 |
Why?
|
| Thrombosis | 1 | 2009 | 781 | 0.220 |
Why?
|
| Patient Acuity | 1 | 2022 | 72 | 0.220 |
Why?
|
| Vascular Resistance | 5 | 2010 | 200 | 0.220 |
Why?
|
| Perioperative Care | 1 | 2006 | 451 | 0.210 |
Why?
|
| Cerebrovascular Circulation | 2 | 2018 | 471 | 0.210 |
Why?
|
| Work Performance | 1 | 2022 | 16 | 0.210 |
Why?
|
| Intraoperative Care | 2 | 2016 | 259 | 0.210 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 261 | 0.200 |
Why?
|
| Workplace | 1 | 2022 | 76 | 0.200 |
Why?
|
| Bronchodilator Agents | 1 | 2003 | 219 | 0.200 |
Why?
|
| Interdisciplinary Placement | 1 | 2021 | 6 | 0.200 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 395 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 7702 | 0.190 |
Why?
|
| Heart Ventricles | 3 | 2018 | 846 | 0.190 |
Why?
|
| Prevalence | 3 | 2016 | 3260 | 0.190 |
Why?
|
| Neurology | 1 | 2022 | 113 | 0.190 |
Why?
|
| Cross-Sectional Studies | 5 | 2023 | 4314 | 0.190 |
Why?
|
| Patient Admission | 1 | 2021 | 220 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2014 | 7222 | 0.180 |
Why?
|
| Blood Flow Velocity | 2 | 2018 | 475 | 0.180 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 175 | 0.180 |
Why?
|
| United States | 5 | 2022 | 15433 | 0.180 |
Why?
|
| Canada | 1 | 2020 | 429 | 0.170 |
Why?
|
| Infant, Premature | 3 | 2020 | 787 | 0.170 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1999 | 44 | 0.170 |
Why?
|
| Confidence Intervals | 2 | 2012 | 756 | 0.170 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 14889 | 0.170 |
Why?
|
| Seizures | 3 | 2023 | 989 | 0.170 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 1999 | 88 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 363 | 0.160 |
Why?
|
| Metabolome | 1 | 2021 | 344 | 0.160 |
Why?
|
| Ventricular Function, Right | 1 | 1999 | 111 | 0.160 |
Why?
|
| Pulmonary Ventilation | 1 | 1997 | 45 | 0.160 |
Why?
|
| Esophageal Atresia | 1 | 2018 | 48 | 0.150 |
Why?
|
| Nutritional Status | 2 | 2023 | 337 | 0.150 |
Why?
|
| Anastomosis, Surgical | 2 | 2018 | 371 | 0.150 |
Why?
|
| Down Syndrome | 1 | 2020 | 226 | 0.150 |
Why?
|
| Arterial Pressure | 1 | 2018 | 107 | 0.150 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2018 | 67 | 0.150 |
Why?
|
| Drug Therapy, Combination | 3 | 2011 | 2315 | 0.150 |
Why?
|
| Brain Diseases | 2 | 2014 | 403 | 0.150 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 316 | 0.150 |
Why?
|
| Heart Atria | 1 | 2019 | 352 | 0.150 |
Why?
|
| Midazolam | 1 | 1997 | 75 | 0.140 |
Why?
|
| Comorbidity | 3 | 2020 | 2352 | 0.140 |
Why?
|
| Psychomotor Disorders | 1 | 2016 | 32 | 0.140 |
Why?
|
| Emotional Adjustment | 1 | 2015 | 7 | 0.140 |
Why?
|
| Sheep | 2 | 2014 | 258 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 4320 | 0.140 |
Why?
|
| Tertiary Care Centers | 2 | 2017 | 403 | 0.140 |
Why?
|
| Learning Curve | 1 | 2016 | 68 | 0.130 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 609 | 0.130 |
Why?
|
| Heart Diseases | 3 | 2018 | 732 | 0.130 |
Why?
|
| Nutrition Policy | 1 | 2016 | 111 | 0.130 |
Why?
|
| Seasons | 3 | 2012 | 340 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2018 | 492 | 0.130 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 445 | 0.130 |
Why?
|
| Hematoma, Subdural | 1 | 2014 | 28 | 0.130 |
Why?
|
| Young Adult | 8 | 2021 | 21445 | 0.120 |
Why?
|
| Failure to Thrive | 1 | 2014 | 91 | 0.120 |
Why?
|
| Blood Pressure | 4 | 2010 | 1467 | 0.120 |
Why?
|
| Shock, Cardiogenic | 2 | 2021 | 228 | 0.120 |
Why?
|
| Health Services Research | 1 | 2016 | 233 | 0.120 |
Why?
|
| Blood Gas Analysis | 1 | 2014 | 100 | 0.120 |
Why?
|
| Child Nutrition Disorders | 1 | 2014 | 77 | 0.120 |
Why?
|
| Neuropsychological Tests | 3 | 2014 | 1178 | 0.120 |
Why?
|
| Reoperation | 1 | 2018 | 1382 | 0.120 |
Why?
|
| Physicians | 1 | 2022 | 882 | 0.120 |
Why?
|
| Registries | 3 | 2020 | 2170 | 0.120 |
Why?
|
| Echoencephalography | 1 | 2013 | 21 | 0.120 |
Why?
|
| Energy Intake | 1 | 2016 | 515 | 0.110 |
Why?
|
| Ischemic Preconditioning | 1 | 2013 | 20 | 0.110 |
Why?
|
| Learning | 1 | 2016 | 403 | 0.110 |
Why?
|
| Cyanosis | 1 | 2013 | 40 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2014 | 218 | 0.110 |
Why?
|
| Infant Mortality | 1 | 2014 | 186 | 0.110 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2013 | 84 | 0.110 |
Why?
|
| Homeostasis | 1 | 2018 | 950 | 0.110 |
Why?
|
| Carotid Arteries | 1 | 2014 | 240 | 0.110 |
Why?
|
| Infusions, Intravenous | 3 | 2006 | 1382 | 0.110 |
Why?
|
| Methylmalonic Acid | 1 | 2012 | 15 | 0.110 |
Why?
|
| Vasoplegia | 1 | 2012 | 10 | 0.110 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 915 | 0.110 |
Why?
|
| Prognosis | 6 | 2017 | 21713 | 0.110 |
Why?
|
| Neuroglia | 1 | 2014 | 223 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 226 | 0.110 |
Why?
|
| Dopamine | 1 | 2014 | 312 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1859 | 0.110 |
Why?
|
| Disease Management | 1 | 2017 | 1052 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2011 | 6009 | 0.100 |
Why?
|
| Lung | 2 | 2006 | 3151 | 0.100 |
Why?
|
| Advisory Committees | 1 | 2012 | 203 | 0.100 |
Why?
|
| Certification | 1 | 2012 | 123 | 0.100 |
Why?
|
| Hypoxia | 1 | 2014 | 443 | 0.100 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 998 | 0.100 |
Why?
|
| Erythropoietin | 1 | 2012 | 205 | 0.100 |
Why?
|
| Patient Care Team | 2 | 2016 | 795 | 0.100 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 158 | 0.100 |
Why?
|
| Perfusion | 1 | 2012 | 293 | 0.100 |
Why?
|
| Incidence | 2 | 2019 | 5673 | 0.100 |
Why?
|
| Cognition | 2 | 2019 | 968 | 0.100 |
Why?
|
| American Heart Association | 1 | 2012 | 310 | 0.100 |
Why?
|
| Benchmarking | 1 | 2012 | 273 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 264 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2018 | 806 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 215 | 0.090 |
Why?
|
| Leadership | 1 | 2013 | 254 | 0.090 |
Why?
|
| Patient Transfer | 2 | 2022 | 137 | 0.090 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2012 | 192 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2012 | 574 | 0.090 |
Why?
|
| Body Composition | 1 | 2013 | 595 | 0.090 |
Why?
|
| Lower Extremity | 1 | 2013 | 299 | 0.090 |
Why?
|
| Videotape Recording | 1 | 2010 | 74 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 244 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2012 | 427 | 0.090 |
Why?
|
| Coma | 1 | 2010 | 61 | 0.090 |
Why?
|
| Guideline Adherence | 3 | 2018 | 636 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2010 | 104 | 0.090 |
Why?
|
| Faculty, Medical | 2 | 2023 | 289 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2014 | 717 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2011 | 170 | 0.090 |
Why?
|
| Blood Coagulation Tests | 1 | 2009 | 87 | 0.090 |
Why?
|
| Anaerobic Threshold | 1 | 2009 | 11 | 0.090 |
Why?
|
| Syndrome | 2 | 2004 | 1351 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2014 | 1819 | 0.090 |
Why?
|
| Lung Transplantation | 1 | 2013 | 359 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 242 | 0.080 |
Why?
|
| Hemorrhage | 1 | 2013 | 712 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2992 | 0.080 |
Why?
|
| Medical Audit | 1 | 2009 | 188 | 0.080 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2009 | 119 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2009 | 445 | 0.080 |
Why?
|
| Terminal Care | 1 | 2012 | 447 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 1129 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2013 | 717 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2012 | 546 | 0.070 |
Why?
|
| Adult | 7 | 2023 | 77950 | 0.070 |
Why?
|
| Catecholamines | 1 | 2006 | 101 | 0.070 |
Why?
|
| Gases | 1 | 2006 | 36 | 0.070 |
Why?
|
| Clinical Protocols | 2 | 2018 | 467 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 88 | 0.070 |
Why?
|
| Hemostasis | 1 | 2006 | 109 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 702 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 891 | 0.070 |
Why?
|
| Respiratory Therapy | 1 | 2005 | 30 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2013 | 1270 | 0.060 |
Why?
|
| Echocardiography | 1 | 2011 | 1182 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2012 | 1230 | 0.060 |
Why?
|
| Pregnancy | 3 | 2022 | 7573 | 0.060 |
Why?
|
| Apgar Score | 1 | 2004 | 55 | 0.060 |
Why?
|
| Cardiac Catheterization | 2 | 2010 | 687 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2010 | 925 | 0.060 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2004 | 74 | 0.060 |
Why?
|
| New Zealand | 2 | 2014 | 60 | 0.060 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 7548 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2011 | 9180 | 0.050 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2003 | 133 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2003 | 125 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2018 | 6100 | 0.050 |
Why?
|
| Australia | 2 | 2014 | 225 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2004 | 553 | 0.050 |
Why?
|
| Animals | 6 | 2014 | 59536 | 0.050 |
Why?
|
| Birth Weight | 1 | 2004 | 374 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2022 | 59 | 0.050 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 603 | 0.050 |
Why?
|
| Patient Readmission | 2 | 2020 | 548 | 0.050 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 48 | 0.050 |
Why?
|
| Prostaglandins | 1 | 2001 | 77 | 0.050 |
Why?
|
| Premature Birth | 1 | 2006 | 407 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 329 | 0.050 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2021 | 136 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 3251 | 0.050 |
Why?
|
| Cause of Death | 1 | 2004 | 752 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 4971 | 0.050 |
Why?
|
| Phenotype | 1 | 2012 | 6295 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2006 | 2588 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2003 | 1313 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2006 | 1863 | 0.040 |
Why?
|
| Air Pressure | 1 | 1999 | 8 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 30 | 0.040 |
Why?
|
| North America | 1 | 2020 | 314 | 0.040 |
Why?
|
| Heart Rate | 2 | 2007 | 737 | 0.040 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1999 | 62 | 0.040 |
Why?
|
| Analgesia | 1 | 2019 | 94 | 0.040 |
Why?
|
| Dexmedetomidine | 1 | 2019 | 85 | 0.040 |
Why?
|
| Benzodiazepines | 1 | 2019 | 170 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 1999 | 173 | 0.040 |
Why?
|
| Academic Success | 1 | 2018 | 22 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 827 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 109 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 1999 | 318 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1225 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2018 | 137 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2001 | 388 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 1997 | 116 | 0.040 |
Why?
|
| Oximetry | 1 | 2018 | 172 | 0.040 |
Why?
|
| Gestational Age | 1 | 2020 | 1069 | 0.040 |
Why?
|
| Epinephrine | 1 | 2018 | 255 | 0.040 |
Why?
|
| Awards and Prizes | 1 | 2018 | 98 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2017 | 111 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 3441 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 543 | 0.040 |
Why?
|
| Standard of Care | 1 | 2018 | 243 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 2522 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2017 | 144 | 0.030 |
Why?
|
| Basal Metabolism | 1 | 2016 | 88 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2016 | 76 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 1085 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2021 | 1145 | 0.030 |
Why?
|
| Mentors | 1 | 2018 | 203 | 0.030 |
Why?
|
| Communication | 1 | 2022 | 876 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 315 | 0.030 |
Why?
|
| Nutritional Requirements | 1 | 2016 | 185 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 693 | 0.030 |
Why?
|
| Device Removal | 1 | 2017 | 337 | 0.030 |
Why?
|
| Growth | 1 | 2014 | 117 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 4892 | 0.030 |
Why?
|
| Models, Biological | 1 | 2003 | 3254 | 0.030 |
Why?
|
| Catheter Obstruction | 1 | 2013 | 8 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 15 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2011 | 677 | 0.030 |
Why?
|
| Tourniquets | 1 | 2013 | 14 | 0.030 |
Why?
|
| Patient Selection | 1 | 2001 | 2055 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2013 | 131 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 1183 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2014 | 167 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2015 | 1391 | 0.030 |
Why?
|
| Palivizumab | 1 | 2012 | 64 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2012 | 111 | 0.030 |
Why?
|
| Troponin I | 1 | 2013 | 127 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2013 | 314 | 0.030 |
Why?
|
| Blood Coagulation Disorders | 1 | 2013 | 120 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 4744 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2012 | 409 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 173 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 209 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2010 | 60 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 185 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 5687 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 1371 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 205 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2011 | 423 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Urea | 1 | 2010 | 290 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 769 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1323 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 2146 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 4298 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2007 | 41 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2013 | 1335 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 383 | 0.020 |
Why?
|
| Diastole | 1 | 2007 | 187 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 488 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 1338 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 2203 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 503 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 3890 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 2450 | 0.010 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 180 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 174 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1374 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 862 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2004 | 1038 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 1073 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 2422 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 1538 | 0.010 |
Why?
|